Makiko Mori

Makiko Mori

Auto-generated profile, based on publicly available information

Makiko Mori

Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2019 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MTMitsuo Terada
Mitsuo Terada
AYAkiyo Yoshimura
Akiyo Yoshimura
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
GNGondo Naomi
Gondo Naomi
Hiroji IwataHiroji Iwata
Hiroji Iwata

26 July 2016 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
YTYujiro Tanaka
Yujiro Tanaka
HKHiroshi Kawashima
Hiroshi Kawashima
MMMakiko Mori
Makiko Mori
MFMichimasa Fujiogi
Michimasa Fujiogi
KSKeisuke Suzuki
Keisuke Suzuki
HUHiroo Uchida
Hiroo Uchida

1 March 2015 in Journal of Occupational Health
Verified
Journal Article
Closed access
RKRisa Kimura
Risa Kimura
MMMakiko Mori
Makiko Mori
MTMiyuki Tajima
Miyuki Tajima
HSHironori Somemura
Hironori Somemura
NSNorio Sasaki
Norio Sasaki
KTKatsutoshi Tanaka
Katsutoshi Tanaka
Effect of a brief training program based on cognitive behavioral therapy in improving work performance: A randomized controlled trial: Risa Kimura, et al. Department of Occupational Mental Health, Graduate School of Medical Science, Kitasato UniversityObjective: Efforts to improve performance in the workplace with respect to positive mental health have increased, and cognitive behavioral therapy (CBT) has recently attracted attention as an intervention measure to this end. Here, we conducted a randomized controlled trial to evaluate the effectiveness of a brief training program on CBT for improving work performance of employees.Methods: The participants were employees of an electric company in Japan. The intervention consisted of 1 group session of CBT (120 min) and web‐based CBT homework for 1 month. We evaluated employees in both the intervention and control groups at baseline and follow‐up after three months. The main outcome was work performance, which was evaluated by a subjective score from 1 to 10. The secondary outcome was self‐evaluation of cognitive flexibility. Analyses were conducted based on ITT.Results: In the intervention group, 84 participants attended the group session, with 79 subsequently completing at least 1 instance of online homework. ITT analysis showed that the subjective performance of the intervention group was significantly improved compared with that of the control group (1.47 vs. 0.69, mean difference 0.78 [95% confidence interval {CI}, 0.05 to 1.51], Cohen's d=0.31). The ability to recognize dysfunctional thinking patterns and change them to positive ones significantly improved in the intervention group compared to the control group (0.71 vs. 0.26, mean difference 0.45 [95% CI 0.06 to 0.83], d=0.33). However, after adjustment for baseline scores, no significant difference was observed. The ability to view a situation from multiple perspectives and expand one's repertoire of thought patterns in the intervention group also significantly improved (0.83 vs. 0.35, mean difference 0.48 [95% CI 0.35 to 0.95], d=0.29), but here again, significance was lost after adjusting for baseline scores. Discussion: Our results suggest that a brief training program that combines a group CBT session with web‐based CBT homework improved subjective work performance. In addition, this program might help improve employees’ cognitive flexibility.

6 September 2023 in JMIR Formative Research
Verified
Journal Article
Open access
NKNari Kureyama
Nari Kureyama
MTMitsuo Terada
Mitsuo Terada
MKMaho Kusudo
Maho Kusudo
KNKazuki Nozawa
Kazuki Nozawa
YWYumi Wanifuchi-Endo
Yumi Wanifuchi-Endo
TTTatsuya Toyama
Tatsuya Toyama
Background: The widespread use of social media has made it easier for patients to access cancer information. However, a large amount of misinformation and harmful information that could negatively impact patients’ decision-making is also disseminated on social media platforms. Objective: We aimed to determine the actual amount of misinformation and harmful information as well as trends in the dissemination of cancer-related information on Twitter, a representative social media platform. Our findings can support decision-making among Japanese patients with cancer. Methods: Using the Twitter app programming interface, we extracted tweets containing the term “cancer” in Japanese that were posted between August and September of 2022. The eligibility criteria were the cancer-related tweets with the following information: (1) reference to the occurrence or prognosis of cancer, (2) recommendation or nonrecommendation of actions, (3) reference to the course of cancer treatment or adverse events, (4) results of cancer research, and (5) other cancer-related knowledge and information. Finally, we selected the top 100 tweets with the highest number of “likes.” For each tweet, 2 independent reviewers evaluated whether the information was factual or misinformation, and whether it was harmful or safe with the reasons for the decisions on the misinformation and harmful tweets. Additionally, we examined the frequency of information dissemination using the number of retweets for the top 100 tweets and investigated trends in the dissemination of information. Results: The extracted tweets totaled 69,875. Of the top 100 cancer-related tweets with the most “likes” that met the eligibility criteria, 44 (44%) contained misinformation, 31 (31%) contained harmful information, and 30 (30%) contained both misinformation and harmful information. Misinformation was described as Unproven (29/94, 40.4%), Disproven (19/94, 20.2%), Inappropriate application (4/94, 4.3%), Strength of evidence mischaracterized (14/94, 14.9%), Misleading (18/94, 18%), and Other misinformation (1/94, 1.1%). Harmful action was described as Harmful action (9/59, 15.2%), Harmful inaction (43/59, 72.9%), Harmful interactions (3/59, 5.1%), Economic harm (3/59, 5.1%), and Other harmful information (1/59, 1.7%). Harmful information was liked more often than safe information (median 95, IQR 43-1919 vs 75.0 IQR 43-10,747; P=.04). The median number of retweets for the leading 100 tweets was 13.5 (IQR 0-2197). Misinformation was retweeted significantly more often than factual information (median 29.0, IQR 0-502 vs 7.5, IQR 0-2197; P=.01); harmful information was also retweeted significantly more often than safe information (median 35.0, IQR 0-502 vs 8.0, IQR 0-2197; P=.002). Conclusions: It is evident that there is a prevalence of misinformation and harmful information related to cancer on Twitter in Japan and it is crucial to increase health literacy and awareness regarding this issue. Furthermore, we believe that it is important for government agencies and health care professionals to continue providing accurate medical information to support patients and their families in making informed decisions.

13 May 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
KKKotani Kotani
Kotani Kotani
MTMitsuo Terada
Mitsuo Terada
MMMakiko Mori
Makiko Mori
NHNanae Horisawa
Nanae Horisawa
KSKayoko Sugino
Kayoko Sugino
Hiroji IwataHiroji Iwata
Hiroji Iwata
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of paclitaxel (PTX). There is no known prophylactic measure, although there are some reports of prevention with compression therapy using surgical gloves. On account of its predominantly subjective symptoms, it is difficult to exclude bias when assessing for CIPN. In this study, we assessed the effectiveness of the same procedure for the prevention of paclitaxel-induced PN based on a double-blind study design. Methods: The patients with early and recurrent breast cancer (with no prior PTX exposure) initiating weekly chemotherapy with PTX 80 mg/m2 were enrolled. Each patient donned two gloves on each hand at every PTX infusion. Two one-size-smaller gloves were donned on one hand (study side) and two normal-size gloves were donned on the other hand (control side) during 90 min from 30 min before the infusion to 30 min after the end of the infusion. Study side are blind for both patients and assessing physicians according to determination of the study side by research nurses in the chemotherapy unit. The primary outcome was the difference in the frequency of CIPN (motor/sensory) determined by the physician using the common terminology criteria for adverse events (CTCAE v4.0), with an evaluation at each cycle of PTX infusion. McNemar test was used to assess the primary outcome. Results: Between July 2017 and November 2018, 56 patients were enrolled and 49 patients were evaluated. Overall, Grade ≥ 2 PN (sensory) was observed in 30.6 and 36.7% in the study and control sides, respectively (McNemar p = 0.25). PN (motor) was observed in 4.1 and 6.1% in the study and control sides, respectively (McNemar p = 1.0). Conclusion: Surgical glove compression therapy showed no statistically significant effect on the incidence of PTX-induced PN. Trial registrations: This study was registered with the University Hospital Medical Information Network (UMIN) Clinical Trials Registry managed by the National University Hospital Council of Japan (UMIN000027944). Registered 26 June 2017.

19 February 2019 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MMMakiko Mori
Makiko Mori
KKKotani Kotani
Kotani Kotani
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
AYAkiyo Yoshimura
Akiyo Yoshimura
Hiroji IwataHiroji Iwata
Hiroji Iwata
Amyloid tumor of the breast is a rare disease, which was first reported in 1973. To date, only six cases have been reported in Japan. A 45-year-old woman who had a medical history of Sjogren’s syndrome presented with a lump of 3 cm in diameter on the outer side of the right breast. Mammography showed no abnormality. Ultrasonography showed a well-defined and rough hypoechoic mass of 32 mm in diameter at the site of the lump. With suspicion of breast cancer, an ultrasound-guided vacuum-assisted breast biopsy was performed. For pathological diagnosis, hematoxylin and eosin staining showed deposits of nonstructural substances in the interstitium. The specimen stained red with Congo red staining and showed green birefringence under a polarizing microscope. Thus, the mass was diagnosed as an amyloid tumor. Since the patient had Sjogren’s syndrome, it was considered a breast finding of autoimmune disease. We considered further therapy to be unnecessary, and annual follow-up was recommended. We diagnosed the mass as an amyloid tumor by an ultrasound-guided vacuum-assisted breast biopsy without resection. The patient had no systemic symptoms suspected systemic amyloidosis, and we diagnosed localized amyloidosis. An amyloid tumor of the breast may show findings suggestive of breast cancer. Pathological diagnosis before surgery is important to avoid excessive invasion. If deposits of nonstructural substances are observed by hematoxylin and eosin staining, Congo red staining should be added.